Britons cautioned on foreign fertility treatment
Posted on: Friday, 28 April 2006, 14:48 CDT
LONDON (Reuters) - Britons were urged on Friday to think twice about going abroad for in vitro fertilization (IVF) and other types of fertility treatment.
The Human fertilization and Embryology Authority (HFEA), which monitors fertility clinics in England and Wales, said couples should think twice about the risks and implications before booking an IVF holiday.
"We know that a relatively small number of people choose to travel abroad to undergo fertility treatment and that sometimes the treatment is packaged as a 'holiday' where the patient can convalesce in the sun," said Suzi Leather, the chair of the
HFEA.
"However we are concerned that people who choose to have their treatment abroad should know about the potential risks," she added in a statement.
The HFEA said patients should consider what happens if something goes wrong, whether their information is kept confidential, the legal position of donors of eggs or sperm and how they are recruited, screened and compensated.
Leather said she has heard stories of foreign clinics offering treatments to patients that could be dangerous, such as implanting five embryos to increase the chances of a pregnancy.
Implanting two or more embryos can increase the odds of having a multiple birth, which can be dangerous for the mother and the babies.
"We would urge patients to think twice and consider the risks and implications before going abroad for treatment," Leather added.
Infertility Network UK, a support organization, backed the HFEA's warning but added that some patients are being forced to travel abroad because they cannot access the treatment they need in Britain.
"The shortage of egg and sperm donors has led to unacceptably long waiting lists in some areas and we know of clinics where the waiting lists have been closed and couples are no longer being accepted for treatment due to the lack of donors," said Clare Brown, the chief executive of the group.
But she added that the standard of care and treatment in other countries may not be as high as it is in Britain.
Infertility affects about one in six couples worldwide. Providing fertility treatment is a multi-billion dollar global industry.
Declining natural fertility, rapid scientific advances in treatment, and a mix of national regulations has prompted couples wanting babies to go abroad for cheaper or quicker procedures or treatments they cannot get at home.
Source: REUTERS
Related Articles
- Local Neurosurgeon Co-Authors National Treatment Guidelines for Brain Tumor Patients
- Sucampo Pharmaceuticals Initiates Phase 2 Trial of Cobiprostone for the Treatment of Portal Hypertension in Patients With Liver Cirrhosis
- St. Jude Medical Announces First Patient Implants in Clinical Study Evaluating Deep Brain Stimulation for Depression
- Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study With CORTIJECT(R) for Diabetic Macular Edema
- NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
- Medivation Announces Treatment of First Patient in Phase 1-2 Clinical Trial of MDV3100 in Hormone-Refractory Prostate Cancer
- New Non-Invasive Treatment Option for Lung Cancer Patients Offered By CyberKnife Center of Miami
- Somaxon Pharmaceuticals to Announce Results of Phase 3 Clinical Trial of SILENOR(TM) for the Treatment of Insomnia in Elderly Patients and Host Conference Call
- MedImmune Begins Dosing of Lupus Patients in Phase 1 Clinical Trial
- GelStat Corporation Completes Patient Enrollment in Clinical Trial of GelStat Migraine in Triptan Users
 |
 |
User Comments (0)
RSS Feeds